Abstract
The purpose of the study was to systematically review and assess the safety and efficacy of hemostatic agents in tubeless percutaneous nephrolithotomy. Original studies on the use of hemostatic agents in tubeless percutaneous nephrolithotomy (PCNL) from January 2001 to March 2014 were searched in Ovid, Science Direct, Pubmed, and Embase by two independent reviewers. A drop in hemoglobin (Hb), analgesic requirements, length of hospital stay, and necessity for blood transfusions were compared using Review Manager 5.2. The methods were done according to the Cochrane Handbook for interventional systematic reviews and written based on the PRISMA Statement. Seven studies involving 351 patients met the inclusion criteria for the meta-analysis. The baseline characteristics were comparable in all of the studies. The results showed that the length of hospital stay was less in the experimental group than in the control group (P < 0.05). There were no significant statistical differences in terms of a drop in Hb, analgesic requirements, and the necessity for a blood transfusion between the two groups (P > 0.05). The meta-analysis indicated that the hemostatic agents in tubeless PCNL were not expected to be unsafe or mandatory, but that they were expected to be expensive. We concluded that hemostatic agents might not be necessary in tubeless PCNL.
Similar content being viewed by others
References
Lingeman JE, Lifshitz DA, Evan AP (2002) Surgical management of urinary lithiasis. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (eds) Campbell’s urology (edn 8). WB Saunders, Philadelphia, pp 3361–3451
Fernström I, Johansson B (1976) Percutaneous pyelolithotomy: a new extraction technique. Scand J Urol Nephrol 10:257–259
Wang J, Zhao C, Zhang C, Fan X, Lin Y, Jiang Q (2012) Tubeless vs. standard percutaneous nephrolithotomy: a meta-analysis. BJU Int 109(6):918–924
Lee DI, Uribe C, Eichel L et al (2004) Sealing percutaneous nephrolithotomy tracts with gelatin matrix hemostatic sealant: initial clinical use. J Urol 171:575–578
Higgins JP, Altman DG, Gotzsche PC et al (2001) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928
Wells GA, Brodsky L, O’Connell D, Shea B, Henry D, et al. (2003) An evaluation of the Newcastle Ottawa scale: an assessment tool for evaluating the quality of NonRandomized studies. In: XI Cochrane Colloquium VolO-63p26 Barcelona: XI International Cochrane Colloquium Book of Abstracts
OCEBM Levels of Evidence Working Group Jeremy Howick ICJLL, Paul Glasziou, Trish Greenhalgh, Carl Heneghan, Alessandro Liberati, Ivan Moschetti, Bob Phillips, Hazel Thornton, Olive Goddard, Mary Hodgkinson (2011) OCEBM levels of evidence working group. “The Oxford 2011 Levels of Evidence’’. Oxford Center for Evidence-Based Medicine
Mikhail AA, Kaptein JS, Bellman GC (2003) Use of fibrin glue in percutaneous nephrolithotomy. Urology 61:910–914
Shah HN, Hegde S, Shah JN et al (2006) A prospective, randomized trial evaluating the safety and efficacy of fibrin sealant in tubeless percutaneous nephrolithotomy. J Urol 176:2488–2493
Shah HN, Kausik V, Hegde S, Shah JN, Bansal MB (2006) Initial experience with hemostatic fibrin glue as adjuvant during tubeless percutaneous nephrolithotomy. J Endourol 20:194–198
Singh I, Saran RN, Jain M (2008) Does sealing of the tract with absorbable gelatin (Spongostan®) facilitate tubeless PCNL? Prospective study. J Endourol 22(11):2485–2494
Istanbulluoğlu MO, Kaynar M, Çiçek T, Koşan M, Öztürk B, Özkardeş H (2013) A new hemostatic agent (Ankaferd Blood Stopper?) in tubeless percutaneous nephrolithotomy: a prospective randomized study. J Endourol 27(9):1126–1130
Li R, Louie MK, Lee HJ, Osann K, Pick DL, Santos R, McDougall EM, Clayman RV (2010) Prospective randomized trial of three different methods of nephrostomy tract closure after percutaneous nephrolithotripsy. BJU Int 107:1660–1665
Ziaee SA, Sarhangnejad R, Abolghasemi H, Eshghi P, Radfar MH, Ahanian A, Kardoust Parizi M, Amirizadeh N, Nouralizadeh A (2013) Autologous fibrin sealant in tubeless percutaneous nephrolithotomy; a prospective study. Urol J 10(3):999–1003
Bellman GC (2006) Re: Aghamir SM, Khazaeli MH, Meisami A. Use of surgicel for sealing nephrostomy tract after totally tubeless percutaneous nephrolithotomy. J Endourol 2006 20:293–295. [letter] J Endourol 2006 20:444
Noller MW, Baughman SM, Morey AF, Auge BK (2004) Fibrin sealant enables tubeless percutaneous stone surgery. J Urol 172(1):166–169
Borin JF, Sala LG, Eichel L, McDougall EM, Clayman RV (2005) Tubeless percutaneous nephrolithotomy using hemostatic gelatin matrix. J Endourol 19(6):614–617 (discussion 617)
Yu DS (2006) Gelatin packing of intracortical tract after percutaneous nephrostomy lithotripsy for decreasing bleeding and urine leakage. J Chin Med Assoc 69:162–165
Rigopoulos C, Kyriazis I, Kallidonis P, Kalogeropoulou C, Koumoundourou D, Georgiopoulos I, Petsas T, Karnabatidis D, Constantinides C, Liatsikos E (2013) Assessing the use of haemostatic sealants in tubeless percutaneous renal access and their effect on renal drainage and histology: an experimental porcine study. BJU Int 112(2):E114–E121
Uribe CA, Eichel L, Khonsari S et al (2005) What happens to hemostatic agents in contact with urine? An in vitro study. J Endourol 19:312–317
Aghamir SM, Khazaeli MH, Meisami A (2006) Use of surgicel for sealing nephrostomy tract after totally tubeless percutaneous nephrolithotomy. J Endourol 20:293–295
Shekarriz B, Stoller ML (2002) The use of fibrin sealant in urology. J Urol 167:1218–1225
Hashemi Teir A, Amirizadeh N, Eshghi P, Abolghasemi H, Amani M, Jabbari A (2009) Study of in vitro properties of fibrin sealant prepared from single donor plasma. Khoon 6:181–189
Kaufmann OG, Sountoulides PG, Kaplan A, Louie M, McDougall E, Clayman R (2009) Skin treatment and tract closure for tubeless percutaneous nephrolithotomy: University of California, Irvine, technique. J Endourol 23:1739–1741
Conflict of interest
We declare that we have no financial, consultant, institutional and personal relationships with other people or organizations that can inappropriately influence our work and lead to bias or a conflict of interest, there is no professional or other personal interest of any nature or kind in any product, service or company that could be construed as influencing the position presented in, or the review of the manuscript entitled ‘The use of adjunctive hemostatic agents in tubeless percutaneous nephrolithotomy:a meta-analysis’ by Jiawu Wang et al.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, J., Zhang, C., Tan, G. et al. The use of adjunctive hemostatic agents in tubeless percutaneous nephrolithotomy: a meta-analysis. Urolithiasis 42, 509–517 (2014). https://doi.org/10.1007/s00240-014-0717-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-014-0717-5